Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”
Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma....
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681569/ |
| id |
pubmed-3681569 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-36815692013-06-14 Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” Ascierto, Paolo A Grimaldi, Antonio M Acquavella, Nicolas Borgognoni, Lorenzo Calabrò, Luana Cascinelli, Natale Cesano, Alessandra Del Vecchio, Michele Eggermont, Alexander M Faries, Mark Ferrone, Soldano Fox, Bernard A Gajewski, Thomas F Galon, Jérôme Gnjatic, Sacha Gogas, Helen Kashani-Sabet, Mohammed Kaufman, Howard L Larkin, James Lo, Roger S Mantovani, Alberto Margolin, Kim Melief, Cornelis McArthur, Grant Palmieri, Giuseppe Puzanov, Igor Ribas, Antoni Seliger, Barbara Sosman, Jeff Suenaert, Peter Tarhini, Ahmad A Trinchieri, Giorgio Vidal-Vanaclocha, Fernando Wang, Ena Ciliberto, Gennaro Mozzillo, Nicola Marincola, Francesco M Thurin, Magdalena Meeting Report Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third “Melanoma Research: “A bridge from Naples to the World” meeting, shortened as “Bridge Melanoma Meeting” took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients. BioMed Central 2013-06-03 /pmc/articles/PMC3681569/ /pubmed/23731854 http://dx.doi.org/10.1186/1479-5876-11-137 Text en Copyright © 2013 Ascierto et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Ascierto, Paolo A Grimaldi, Antonio M Acquavella, Nicolas Borgognoni, Lorenzo Calabrò, Luana Cascinelli, Natale Cesano, Alessandra Del Vecchio, Michele Eggermont, Alexander M Faries, Mark Ferrone, Soldano Fox, Bernard A Gajewski, Thomas F Galon, Jérôme Gnjatic, Sacha Gogas, Helen Kashani-Sabet, Mohammed Kaufman, Howard L Larkin, James Lo, Roger S Mantovani, Alberto Margolin, Kim Melief, Cornelis McArthur, Grant Palmieri, Giuseppe Puzanov, Igor Ribas, Antoni Seliger, Barbara Sosman, Jeff Suenaert, Peter Tarhini, Ahmad A Trinchieri, Giorgio Vidal-Vanaclocha, Fernando Wang, Ena Ciliberto, Gennaro Mozzillo, Nicola Marincola, Francesco M Thurin, Magdalena |
| spellingShingle |
Ascierto, Paolo A Grimaldi, Antonio M Acquavella, Nicolas Borgognoni, Lorenzo Calabrò, Luana Cascinelli, Natale Cesano, Alessandra Del Vecchio, Michele Eggermont, Alexander M Faries, Mark Ferrone, Soldano Fox, Bernard A Gajewski, Thomas F Galon, Jérôme Gnjatic, Sacha Gogas, Helen Kashani-Sabet, Mohammed Kaufman, Howard L Larkin, James Lo, Roger S Mantovani, Alberto Margolin, Kim Melief, Cornelis McArthur, Grant Palmieri, Giuseppe Puzanov, Igor Ribas, Antoni Seliger, Barbara Sosman, Jeff Suenaert, Peter Tarhini, Ahmad A Trinchieri, Giorgio Vidal-Vanaclocha, Fernando Wang, Ena Ciliberto, Gennaro Mozzillo, Nicola Marincola, Francesco M Thurin, Magdalena Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” |
| author_facet |
Ascierto, Paolo A Grimaldi, Antonio M Acquavella, Nicolas Borgognoni, Lorenzo Calabrò, Luana Cascinelli, Natale Cesano, Alessandra Del Vecchio, Michele Eggermont, Alexander M Faries, Mark Ferrone, Soldano Fox, Bernard A Gajewski, Thomas F Galon, Jérôme Gnjatic, Sacha Gogas, Helen Kashani-Sabet, Mohammed Kaufman, Howard L Larkin, James Lo, Roger S Mantovani, Alberto Margolin, Kim Melief, Cornelis McArthur, Grant Palmieri, Giuseppe Puzanov, Igor Ribas, Antoni Seliger, Barbara Sosman, Jeff Suenaert, Peter Tarhini, Ahmad A Trinchieri, Giorgio Vidal-Vanaclocha, Fernando Wang, Ena Ciliberto, Gennaro Mozzillo, Nicola Marincola, Francesco M Thurin, Magdalena |
| author_sort |
Ascierto, Paolo A |
| title |
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” |
| title_short |
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” |
| title_full |
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” |
| title_fullStr |
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” |
| title_full_unstemmed |
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” |
| title_sort |
future perspectives in melanoma research. meeting report from the “melanoma bridge. napoli, december 2nd-4th 2012” |
| description |
Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third “Melanoma Research: “A bridge from Naples to the World” meeting, shortened as “Bridge Melanoma Meeting” took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients. |
| publisher |
BioMed Central |
| publishDate |
2013 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681569/ |
| _version_ |
1611986243571154944 |